SLS
SELLAS Life Sciences GroupCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SLS vs peer average
51/100
SLS vs. peer average (C vs. C)
Grade spread
A 3 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ADMA is the first available peer comparator.
Same-sector, similar-market-cap candidate from the packet; useful only as broad biotech valuation and volatility context because no direct AML or program overlap is established.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SLS
SELLAS Life Sciences Group
ADMA
ADMA Biologics
Grade
C
A
Momentum
85
93
Value
41
65
Sentiment
64
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ADMA
SLS / ADMA
Grade Position
In line
SLS vs. peer average (C vs. C)
51/100
Momentum
85
ADMAValue
41
ADMASentiment
64
SLSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SLS
ADMA is the first peer returned for this comparison set.